Literature DB >> 18484640

QSAR study of malonyl-CoA decarboxylase inhibitors using GA-MLR and a new strategy of consensus modeling.

Jiazhong Li1, Beilei Lei, Huanxiang Liu, Shuyan Li, Xiaojun Yao, Mancang Liu, Paola Gramatica.   

Abstract

Quantitative structure-activity relationship (QSAR) of a series of structural diverse malonyl-CoA decarboxylase (MCD) inhibitors have been investigated by using the predictive single model as well as the consensus analysis based on a new strategy proposed by us. Self-organizing map (SOM) neural network was employed to divide the whole data set into representative training set and test set. Then a multiple linear regressions (MLR) model population was built based on the theoretical molecular descriptors selected by Genetic Algorithm using the training set. In order to analyze the diversity of these models, multidimensional scaling (MDS) was employed to explore the model space based on the Hamming distance matrix calculated from each two models. In this space, Q(2) (cross-validated R(2)) guided model selection (QGMS) strategy was performed to select submodels. Then consensus modeling was built by two strategies, average consensus model (ACM) and weighted consensus model (WCM), where each submodel had a different weight according to the contribution of model expressed by MLR regression coefficients. The obtained results prove that QGMS is a reliable and practical method to guide the submodel selection in consensus modeling building and our weighted consensus model (WCM) strategy is superior to the simple ACM. 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18484640     DOI: 10.1002/jcc.21002

Source DB:  PubMed          Journal:  J Comput Chem        ISSN: 0192-8651            Impact factor:   3.376


  8 in total

1.  Quantitative Structure-Property Relationship for pH-Triggered Drug Release Performance of Acid-Responsive Four/Six-Arms Star Polymeric Micelles.

Authors:  Ran Zhang; Li-Yang Wen; Wen-Sheng Wu; Xiao-Zhe Yuan; Li-Juan Zhang
Journal:  Pharm Res       Date:  2018-12-03       Impact factor: 4.200

2.  QSAR classification of metabolic activation of chemicals into covalently reactive species.

Authors:  Chin Yee Liew; Chuen Pan; Andre Tan; Ke Xin Magneline Ang; Chun Wei Yap
Journal:  Mol Divers       Date:  2012-02-28       Impact factor: 2.943

3.  Mixed learning algorithms and features ensemble in hepatotoxicity prediction.

Authors:  Chin Yee Liew; Yen Ching Lim; Chun Wei Yap
Journal:  J Comput Aided Mol Des       Date:  2011-09-06       Impact factor: 3.686

4.  ADMET evaluation in drug discovery: 15. Accurate prediction of rat oral acute toxicity using relevance vector machine and consensus modeling.

Authors:  Tailong Lei; Youyong Li; Yunlong Song; Dan Li; Huiyong Sun; Tingjun Hou
Journal:  J Cheminform       Date:  2016-02-01       Impact factor: 5.514

5.  Estimation of acute oral toxicity in rat using local lazy learning.

Authors:  Jing Lu; Jianlong Peng; Jinan Wang; Qiancheng Shen; Yi Bi; Likun Gong; Mingyue Zheng; Xiaomin Luo; Weiliang Zhu; Hualiang Jiang; Kaixian Chen
Journal:  J Cheminform       Date:  2014-05-16       Impact factor: 5.514

6.  Identification of Novel Inhibitors of Organic Anion Transporting Polypeptides 1B1 and 1B3 (OATP1B1 and OATP1B3) Using a Consensus Vote of Six Classification Models.

Authors:  Eleni Kotsampasakou; Stefan Brenner; Walter Jäger; Gerhard F Ecker
Journal:  Mol Pharm       Date:  2015-11-02       Impact factor: 4.939

7.  QSAR study of HCV NS5B polymerase inhibitors using the genetic algorithm-multiple linear regression (GA-MLR).

Authors:  Hamid Rafiei; Marziyeh Khanzadeh; Shahla Mozaffari; Mohammad Hassan Bostanifar; Zhila Mohajeri Avval; Reza Aalizadeh; Eslam Pourbasheer
Journal:  EXCLI J       Date:  2016-01-18       Impact factor: 4.068

8.  On detour index of cycloparaphenylene and polyphenylene molecular structures.

Authors:  S Prabhu; Y Sherlin Nisha; M Arulperumjothi; D Sagaya Rani Jeba; V Manimozhi
Journal:  Sci Rep       Date:  2021-07-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.